Northwestern Mutual Wealth Management CO Amgen Inc Transaction History

Northwestern Mutual Wealth Management CO

$101 Billion
Q2 2024

A detailed history of Northwestern Mutual Wealth Management CO transactions in Amgen Inc stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 51,851 shares of AMGN stock, worth $16.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

51,851

Previous 49,931 3.85%

Holding current value

$16.5 Million

Previous $14.2 Million 14.12%

% of portfolio

0.02%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$262.75 - $319.31 $504,480 - $613,075	1,920 Added 3.85%	51,851 $16.2 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $202,459 - $244,393	-753 Reduced 1.49%	49,931 $14.2 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $79,522 - $89,711	-311 Reduced 0.61%	50,684 $14.6 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $571,551 - $709,596	-2,614 Reduced 4.88%	50,995 $13.7 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $310,477 - $367,133	1,449 Added 2.78%	53,609 $11.9 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $589,537 - $718,547	-2,611 Reduced 4.77%	52,160 $12.6 Million
Q4 2022 Feb 21, 2023	BUY	$229.03 - $291.01 $253,536 - $322,148	1,107 Added 2.06%	54,771 $14.4 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $1.22 Million - $1.38 Million	-5,451 Reduced 9.22%	53,664 $12.1 Million
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $54,678 - $60,847	237 Added 0.4%	59,115 $14.4 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $1.16 Million - $1.29 Million	5,301 Added 9.89%	58,878 $14.2 Million
Q4 2021 Feb 03, 2022	BUY	$198.88 - $227.6 $10,341 - $11,835	52 Added 0.1%	53,577 $12.1 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $334,325 - $391,702	1,575 Added 3.03%	53,525 $11.4 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $547,044 - $606,905	-2,342 Reduced 4.31%	51,950 $12.7 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $502,182 - $585,211	-2,263 Reduced 4.0%	54,292 $13.5 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $300,768 - $358,161	1,390 Added 2.52%	56,555 $13 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $60,539 - $67,325	258 Added 0.47%	55,165 $14 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $109,191 - $133,992	552 Added 1.02%	54,907 $13 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $158,366 - $210,037	-869 Reduced 1.57%	54,355 $11 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $1.31 Million - $1.68 Million	-6,900 Reduced 11.11%	55,224 $13.3 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $26,812 - $32,127	-154 Reduced 0.25%	62,124 $12 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $10.3 Million - $12.1 Million	-61,954 Reduced 49.87%	62,278 $11.5 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $1.41 Million - $1.59 Million	7,823 Added 6.72%	124,232 $23.6 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $246,727 - $288,009	1,383 Added 1.2%	116,409 $22.7 Million
Q3 2018 Nov 01, 2018	BUY	$185.29 - $208.89 $228,462 - $257,561	1,233 Added 1.08%	115,026 $23.8 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $852,666 - $957,728	-5,135 Reduced 4.32%	113,793 $21 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $388,502 - $454,014	2,293 Added 1.97%	118,928 $20.3 Million
Q4 2017 Jan 31, 2018	BUY	$168.79 - $188.59 $724,784 - $809,805	4,294 Added 3.82%	116,635 $20.3 Million
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $1.53 Million - $1.75 Million	9,153 Added 8.87%	112,341 $20.9 Million
Q2 2017 Aug 10, 2017	BUY	N/A	103,188	103,188 $17.8 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.

Account

Northwestern Mutual Wealth Management CO Amgen Inc Transaction History